Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. xpefundus

XpeFundus SIGNED

A smart hyperspectral system for early, non-invasive diagnosis of retinal disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 XpeFundus project word cloud

Explore the words cloud of the XpeFundus project. It provides you a very rough idea of what is the project "XpeFundus" about.

spectroscopy    relies    agriculture    medical    xpectraltek    see    stagnated    heritage    diseases    vr    perform    intensities    backed    retinal    light    leveraging    coming    patented    earlier    valuable    market    imaging    human    evaluation    disorders    poised    million    visualisation    diagnostics    prevent    mapping    laser    body    tissue    startup    fundamental    entering    successfully    treatment    cameras    excessive    completely    sight    computer    time    expertise    diagnostic    invasive    3x    irradiation    software    2025    extreme    diabetes    patient    nature    complete    98    pathology    alterations    assets    ophthalmologists    eye    empowers    data    visual    prove    fact    fundus    radically    business    ing    vivo    smart    prevalence    powered    confident    prototype    redundant    right    rising    camera    incidence    prognosis    743    hyperspectral    vision    clinical    xpefundus    background    ocular    doctor    commercialised    pandemic    tool    rapid    objects    global    diagnosis    cultural    education    aggravated    ai    leads   

Project "XpeFundus" data sheet

The following table provides information about the project.

Coordinator		 XPECTRALTEK, LDA 

Organization address
address: TRAVESSA DOS PRADOS 12
city: BRAGA
postcode: 4705-827
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    XPECTRALTEK, LDA PT (BRAGA) coordinator 50˙000.00

Map

 Project objective

The future of retinal diagnostics relies on data-backed smart devices that can see beyond the human eye. With a rising incidence of eye-related diseases further aggravated by the diabetes pandemic, early diagnosis and treatment could prevent up to 98% of sight loss resulting from diabetes. Advances in retinal imaging are in fact fundamental to our understanding and treatment of ocular diseases. XpectralTEK is a European startup focused on the development of imaging diagnostics that aim to improve the visualisation of objects, nature and the human body. By leveraging our expertise in spectroscopy, imaging and computer vision we developed a new hyperspectral fundus camera, XpeFundus. Our camera is capable to perform in-vivo retinal spectroscopy without excessive irradiation making the extreme light intensities and invasive diagnostic methods completely redundant and radically improving the patient experience. Through 3x improved visual mapping of eye tissue alterations, the doctor makes an earlier diagnosis of retinal pathology which leads to earlier prognosis and treatment. Backed by an AI-powered visualisation software and VR, our camera is a complete diagnostic tool that empowers ophthalmologists towards the rapid and non-invasive clinical evaluation of retinal diseases but can also prove a valuable tool for laser treatment, future doctor education and medical research. With the Global Fundus Cameras Market poised to reach a value of $743.3 million by 2025, we are confident that XpeFundus is coming to the market at the right time. Due to the increasing prevalence of eye disorders but also the stagnated number of new ophthalmologists entering the field, advances in retinal diagnostics are a global market high priority. We have already successfully commercialised our patented prototype for its application in cultural heritage and agriculture and we are confident that our business and medical background will be strong assets to bring XpeFundus to the medical market.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "XPEFUNDUS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "XPEFUNDUS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

MycoProScale (2020)

MycoProScale – Creating global markets with a unique large-scale Mycorrhiza production method

Read More  

Neuron-AFib (2019)

Commercialising cardiac autonomic modulation to treat Atrial Fibrillation

Read More